Emerging opportunities to treat idiopathic pulmonary fibrosis: Design, discovery, and optimizations of small-molecule drugs targeting fibrogenic pathways-Reference-Cited by-同舟云学术

Emerging opportunities to treat idiopathic pulmonary fibrosis: Design, discovery, and optimizations of small-molecule drugs targeting fibrogenic pathways

Published:2023-11 Issue: Volume:260 Page:115762
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Luo Wenxin,Gu Yilin,Fu Siyu,Wang Jiaxing,Zhang Jifa,Wang Yuxi

Funder

National Natural Science Foundation of China

Science and Technology Department of Sichuan Province

Sichuan Province Science and Technology Support Program

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference437 articles.

1. Inflammation and immunity in IPF pathogenesis and treatment;Heukels;Respir. Med.,2019

2. Idiopathic pulmonary fibrosis;Richeldi;Lancet,2017

3. Time for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic?;Wolters;Lancet Respir. Med.,2018

4. Demystifying idiopathic interstitial pneumonia: time for more etiology-focused nomenclature in interstitial lung disease;Todd;Expet Rev. Respir. Med.,2022

5. Global incidence and prevalence of idiopathic pulmonary fibrosis;Maher;Respir. Res.,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Idiopathic Pulmonary Fibrosis: From Common Microscopy to Single-Cell Biology and Precision Medicine;American Journal of Respiratory and Critical Care Medicine;2024-05-01

2. Integrated multiomic analysis identifiesTRIP13as a mediator of alveolar epithelial type II cell dysfunction in idiopathic pulmonary fibrosis;2024-04-12